Asthma G.A.P.

Full Survey Findings (PDF)

Survey Findings

An additional 1779 asthma patients in six “select metro areas” were selected to complement those from the national sample in order to achieve a total sample of over 300 asthma suffers from each of the New York (n=342), Los Angeles (n=319), Chicago (n=318), Dallas-Fort Worth (n=316), Boston (n=317), and Atlanta (n=311) metropolitan areas. The following findings have been culled out for four specific regions of the U.S.: Western, South, Midwest and Northeast.

• Asthma patients in the Western region tend to take rescue medication more than do those in the South, Midwest and the Northeast: 70%, 58%, 57% and 54%, respectively.
• Compared with 27% of the general population, 34% of asthma patients from the Western region believe they are not doing enough to reduce the risks associated with asthma. Fewer patients in the Midwest and Northeast believe they're not doing enough to reduce asthma risks (24% and 23%, respectively).
• Patients from the West are more likely to have never taken a controller medication (17%, compared with 10% of the general population) than those in the South (8%) and the Northeast (6%).
• A greater proportion of patients in the West are currently taking a rescue medication (70%, compared with 59% of the general asthma population) than in any other region (58% in the South, 57% in the Midwest and 54% in the Northeast).
• Among patients who have taken controllers in the past year, three in ten asthma patients in the West (31%) report having stopped taking their controller medication in the past year, compared with 21% of the general asthma population. In comparison, just 18% of those in the South and 17% of those in the Midwest have stopped their controller in the past 12 months.
• Asthma patients from the South are more likely to feel asthma symptoms most often at night (27%) than are those from the Midwest (17%).

∧ back to top